
iSpecimen Investor Relations Material
Latest events

Q2 2024
iSpecimen

Q2 2025
14 Aug, 2025

Q1 2025
18 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from iSpecimen Inc
Access all reports
iSpecimen Inc. is a technology-driven company that connects researchers with human biospecimens for medical research and development. Through its proprietary online marketplace, the company facilitates the procurement of biological samples, including blood, tissue, and other biofluids, from a global network of healthcare providers. iSpecimen serves pharmaceutical companies, biotechnology firms, academic institutions, and government organizations involved in drug discovery, diagnostics, and precision medicine. iSpecimen Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ISPC
Country
🇺🇸 United States